首页> 外国专利> Reversal of General Anesthesia by Administration of Methylphenidate, Amphetamine, Modafinil, Amantadine, and/or Caffeine

Reversal of General Anesthesia by Administration of Methylphenidate, Amphetamine, Modafinil, Amantadine, and/or Caffeine

机译:服用哌醋甲酯,苯丙胺,莫达非尼,金刚烷胺和/或咖啡因可逆转全身麻醉

摘要

The present invention generally relates to compositions comprising anesthesia-reversing agents which facilitate or increase the time of awakening or reverse the effects of general anesthesia-induced unconsciousness. In some embodiments, the anesthesia reversing agent can be selected from any or a combination of methylphenidate (MPH), amphetamine, modafinil, amantadine, caffeine, or analogues or derivatives thereof. In some embodiments, compositions comprising at least one or more anesthesia-reversing agents can be used to facilitate awakening from anesthesia without or decreasing occurrence of delirium, and can be used in methods to treat or prevent the symptoms associated with emergence delirium, as well as treat a subject oversedated with general anesthesia. The invention also relates to methods for administering these compositions comprising anesthesia-reversing agents to subjects and for use.
机译:本发明一般涉及包含麻醉逆转剂的组合物,所述麻醉逆转剂促进或增加唤醒时间或逆转全身麻醉引起的意识丧失的作用。在一些实施方案中,麻醉剂可选自哌醋甲酯(MPH),苯丙胺,莫达非尼,金刚烷胺,咖啡因或其类似物或衍生物中的任一种或组合。在一些实施方案中,包含至少一种或多种麻醉逆转剂的组合物可以用于促进从麻醉中苏醒,而没有或减少occurrence妄的发生,并且可以用于治疗或预防与emerge妄发作相关的症状的方法,以及治疗过度麻醉的对象。本发明还涉及将包含麻醉逆转剂的这些组合物施用于受试者和使用的方法。

著录项

  • 公开/公告号US2020029892A1

    专利类型

  • 公开/公告日2020-01-30

    原文格式PDF

  • 申请/专利权人 THE GENERAL HOSPITAL CORPORATION;

    申请/专利号US201916578002

  • 发明设计人 EMERY N. BROWN;PATRICK L. PURDON;

    申请日2019-09-20

  • 分类号A61B5;A61K31/13;A61K31/137;A61K31/165;A61K31/522;A61K45/06;A61K31/4458;A61B5/04;A61B5/0476;

  • 国家 US

  • 入库时间 2022-08-21 11:21:04

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号